Independence Bank of Kentucky’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.7K Hold
1,500
﹤0.01% 460
2026
Q1
$20.8K Sell
1,500
-775
-34% -$10.8K ﹤0.01% 482
2025
Q4
$31.9K Hold
2,275
﹤0.01% 448
2025
Q3
$31.8K Hold
2,275
﹤0.01% 453
2025
Q2
$34.2K Hold
2,275
﹤0.01% 432
2025
Q1
$30K Sell
2,275
-500
-18% -$6.9K ﹤0.01% 441
2024
Q4
$43.8K Hold
2,775
0.01% 409
2024
Q3
$44.1K Buy
2,775
+2,500
+909% +$40.2K 0.01% 377
2024
Q2
$4.19K Hold
275
﹤0.01% 493
2024
Q1
$4.03K Hold
275
﹤0.01% 485
2023
Q4
$3.83K Hold
275
﹤0.01% 479
2023
Q3
$3.68K Hold
275
﹤0.01% 450
2023
Q2
$3.47K Hold
275
﹤0.01% 455
2023
Q1
$3.13K Buy
+275
New +$2.97K ﹤0.01% 404

Other funds holding RDY

Independence Bank of Kentucky's RDY Position: Q2 2026 in Review

Independence Bank of Kentucky held its Dr. Reddy's Laboratories (RDY) position steady in Q2 2026 at 1,500 shares worth $21.7K. The position accounts for ﹤0.01% of the portfolio, ranked #460.

Independence Bank of Kentucky first reported a position in RDY in Q1 2023 and has held it in 14 quarters since. The position peaked at $44.1K in Q3 2024. 101 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Independence Bank of Kentucky held 1,500 shares of Dr. Reddy's Laboratories worth $21.7K as of Q2 2026.
  • Independence Bank of Kentucky left its Dr. Reddy's Laboratories share count unchanged in Q2 2026.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Independence Bank of Kentucky's portfolio in Q2 2026, its #460 holding.
  • Independence Bank of Kentucky first reported a position in Dr. Reddy's Laboratories in Q1 2023 and has held it in 14 quarters since.
  • Independence Bank of Kentucky's Dr. Reddy's Laboratories position peaked at $44.1K in Q3 2024.
  • 101 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Independence Bank of Kentucky's 13F filing for Q2 2026, filed 13 Jul 2026.